APO Research
Talk to an analyst

APO RESEARCH · REPORT

Fertility Enhancing Treatment

Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.

Selected research

Market Outlook & Growth Opportunities

Global Fertility Enhancing Treatment Market Outlook and Growth Opportunities 2026

21 December 2025190 pages

Choose your research edition.

Industry ResearchFertility Enhancing Treatment Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Fertility Enhancing Treatment Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Fertility Enhancing Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fertility Enhancing Treatment Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Fertility Enhancing Treatment Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.

Global Fertility Enhancing Treatment key players include Merck, Ferring, MSD, LIVZON, Abbott, etc. Global top five manufacturers hold a share about 60%.

North America is the largest market, with a share over 30%, followed by China, and Europe, both have a share about 40 percent.

Read the full market overview

In terms of product, Fertility Drugs for Women is the largest segment, with a share over 85%. And in terms of application, the largest application is Drug Stores, followed by Hospitals, Online, etc.

This report provides an overview of the global Fertility Enhancing Treatment market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Fertility Enhancing Treatment and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Fertility Enhancing Treatment revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Fertility Enhancing Treatment market.

Fertility Enhancing Treatment Segment by Company

Merck

Ferring

MSD

LIVZON

Abbott

Bayer Zydus Pharma

Church＆Dwight

SASMAR

BioFilm,Inc

FAIRHAVEN HEALTH

The YES YES Company

Fertility Enhancing Treatment Segment by Type

Fertility Drugs for Women

Fertility Drugs for Men

OTC Conception Gels/Lubricants

Fertility Enhancing Treatment Segment by Application

Hospitals

Drug Stores

Online

Fertility Enhancing Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Fertility Enhancing Treatment status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Fertility Enhancing Treatment key companies, revenue, market share, and recent developments.

3. To split the Fertility Enhancing Treatment breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Fertility Enhancing Treatment market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Fertility Enhancing Treatment significant trends, drivers, influence factors in global and regions.

6. To analyze Fertility Enhancing Treatment competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fertility Enhancing Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fertility Enhancing Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fertility Enhancing Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Fertility Enhancing Treatment industry.

Chapter 3: Detailed analysis of Fertility Enhancing Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Fertility Enhancing Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Fertility Enhancing Treatment in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Fertility Enhancing Treatment Industry Trends Table 2. Fertility Enhancing Treatment Industry Drivers Table 3. Fertility Enhancing Treatment Industry Opportunities and Challenges Table 4. Fertility Enhancing Treatment Industry Restraints Table 5. Global Fertility Enhancing Treatment Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Fertility Enhancing Treatment Revenue Share by Company (2021-2026) Table 7. Global Fertility Enhancing Treatment Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Fertility Enhancing Treatment Key Company Manufacturing Base & Headquarters Table 9. Global Fertility Enhancing Treatment Company, Product Type & Application Table 10. Global Fertility Enhancing Treatment Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Fertility Enhancing Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Fertility Drugs for Women Table 15. Significant Companies of Fertility Drugs for Men Table 16. Significant Companies of OTC Conception Gels/Lubricants Table 17. Global Fertility Enhancing Treatment Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Fertility Enhancing Treatment Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Fertility Enhancing Treatment Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Fertility Enhancing Treatment Sales Value Share by Type (2021-2026) Table 21. Global Fertility Enhancing Treatment Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospitals Table 23. Significant Companies of Drug Stores Table 24. Significant Companies of Online Table 25. Global Fertility Enhancing Treatment Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Fertility Enhancing Treatment Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Fertility Enhancing Treatment Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Fertility Enhancing Treatment Sales Value Share by Application (2021-2026) Table 29. Global Fertility Enhancing Treatment Sales Value Share by Application (2027-2032) Table 30. Global Fertility Enhancing Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Fertility Enhancing Treatment Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Fertility Enhancing Treatment Sales Value Share by Region (2021-2026) Table 33. Global Fertility Enhancing Treatment Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Fertility Enhancing Treatment Sales Value Share by Region (2027-2032) Table 35. Global Fertility Enhancing Treatment Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Fertility Enhancing Treatment Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Fertility Enhancing Treatment Sales Value Market Share by Country (2021-2026) Table 38. Global Fertility Enhancing Treatment Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Fertility Enhancing Treatment Sales Value Market Share by Country (2027-2032) Table 40. Merck Company Information Table 41. Merck Business Overview Table 42. Merck Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Merck Fertility Enhancing Treatment Product Portfolio Table 44. Merck Recent Development Table 45. Ferring Company Information Table 46. Ferring Business Overview Table 47. Ferring Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Ferring Fertility Enhancing Treatment Product Portfolio Table 49. Ferring Recent Development Table 50. MSD Company Information Table 51. MSD Business Overview Table 52. MSD Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. MSD Fertility Enhancing Treatment Product Portfolio Table 54. MSD Recent Development Table 55. LIVZON Company Information Table 56. LIVZON Business Overview Table 57. LIVZON Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. LIVZON Fertility Enhancing Treatment Product Portfolio Table 59. LIVZON Recent Development Table 60. Abbott Company Information Table 61. Abbott Business Overview Table 62. Abbott Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Abbott Fertility Enhancing Treatment Product Portfolio Table 64. Abbott Recent Development Table 65. Bayer Zydus Pharma Company Information Table 66. Bayer Zydus Pharma Business Overview Table 67. Bayer Zydus Pharma Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Bayer Zydus Pharma Fertility Enhancing Treatment Product Portfolio Table 69. Bayer Zydus Pharma Recent Development Table 70. Church＆Dwight Company Information Table 71. Church＆Dwight Business Overview Table 72. Church＆Dwight Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Church＆Dwight Fertility Enhancing Treatment Product Portfolio Table 74. Church＆Dwight Recent Development Table 75. SASMAR Company Information Table 76. SASMAR Business Overview Table 77. SASMAR Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. SASMAR Fertility Enhancing Treatment Product Portfolio Table 79. SASMAR Recent Development Table 80. BioFilm,Inc Company Information Table 81. BioFilm,Inc Business Overview Table 82. BioFilm,Inc Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. BioFilm,Inc Fertility Enhancing Treatment Product Portfolio Table 84. BioFilm,Inc Recent Development Table 85. FAIRHAVEN HEALTH Company Information Table 86. FAIRHAVEN HEALTH Business Overview Table 87. FAIRHAVEN HEALTH Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. FAIRHAVEN HEALTH Fertility Enhancing Treatment Product Portfolio Table 89. FAIRHAVEN HEALTH Recent Development Table 90. The YES YES Company Company Information Table 91. The YES YES Company Business Overview Table 92. The YES YES Company Fertility Enhancing Treatment Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. The YES YES Company Fertility Enhancing Treatment Product Portfolio Table 94. The YES YES Company Recent Development Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Fertility Enhancing Treatment Product Image Figure 2. Global Fertility Enhancing Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fertility Enhancing Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Fertility Enhancing Treatment Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Fertility Drugs for Women Image Figure 8. Fertility Drugs for Men Image Figure 9. OTC Conception Gels/Lubricants Image Figure 10. Global Fertility Enhancing Treatment Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Fertility Enhancing Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Fertility Enhancing Treatment Sales Value Share by Type (2021-2032) Figure 13. Hospitals Image Figure 14. Drug Stores Image Figure 15. Online Image Figure 16. Global Fertility Enhancing Treatment Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Fertility Enhancing Treatment Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Fertility Enhancing Treatment Sales Value Share by Application (2021-2032) Figure 19. Global Fertility Enhancing Treatment Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Fertility Enhancing Treatment Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Fertility Enhancing Treatment Sales Value (2021-2032) & (US$ Million) Figure 22. North America Fertility Enhancing Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Fertility Enhancing Treatment Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Fertility Enhancing Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Fertility Enhancing Treatment Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Fertility Enhancing Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Fertility Enhancing Treatment Sales Value (2021-2032) & (US$ Million) Figure 28. South America Fertility Enhancing Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Fertility Enhancing Treatment Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Fertility Enhancing Treatment Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Fertility Drugs for Women
  • Fertility Drugs for Men
  • OTC Conception Gels/Lubricants
Applications
  • Hospitals
  • Drug Stores
  • Online
Companies covered
  • Merck
  • Ferring
  • MSD
  • LIVZON
  • Abbott
  • Bayer Zydus Pharma
  • Church＆Dwight
  • SASMAR
  • BioFilm,Inc
  • FAIRHAVEN HEALTH
  • The YES YES Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Fertility Enhancing Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Fertility Enhancing Treatment Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Fertility Enhancing Treatment Market Dynamics
  1. 2.1 Fertility Enhancing Treatment Industry Trends
  2. 2.2 Fertility Enhancing Treatment Industry Drivers
  3. 2.3 Fertility Enhancing Treatment Industry Opportunities and Challenges
  4. 2.4 Fertility Enhancing Treatment Industry Restraints
3 Fertility Enhancing Treatment Market by Company
  1. 3.1 Global Fertility Enhancing Treatment Company Revenue Ranking in 2025
  2. 3.2 Global Fertility Enhancing Treatment Revenue by Company (2021-2026)
  3. 3.3 Global Fertility Enhancing Treatment Company Ranking (2024-2026)
  4. 3.4 Global Fertility Enhancing Treatment Company Manufacturing Base and Headquarters
  5. 3.5 Global Fertility Enhancing Treatment Company Product Type and Application
  6. 3.6 Global Fertility Enhancing Treatment Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Fertility Enhancing Treatment Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Fertility Enhancing Treatment Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Fertility Enhancing Treatment Market by Type
  1. 4.1 Fertility Enhancing Treatment Type Introduction
  2. 4.1.1 Fertility Drugs for Women
  3. 4.1.2 Fertility Drugs for Men
  4. 4.1.3 OTC Conception Gels/Lubricants
  5. 4.2 Global Fertility Enhancing Treatment Sales Value by Type
  6. 4.2.1 Global Fertility Enhancing Treatment Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Fertility Enhancing Treatment Sales Value by Type (2021-2032)
  8. 4.2.3 Global Fertility Enhancing Treatment Sales Value Share by Type (2021-2032)
5 Fertility Enhancing Treatment Market by Application
  1. 5.1 Fertility Enhancing Treatment Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Drug Stores
  4. 5.1.3 Online
  5. 5.2 Global Fertility Enhancing Treatment Sales Value by Application
  6. 5.2.1 Global Fertility Enhancing Treatment Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Fertility Enhancing Treatment Sales Value by Application (2021-2032)
  8. 5.2.3 Global Fertility Enhancing Treatment Sales Value Share by Application (2021-2032)
6 Fertility Enhancing Treatment Regional Value Analysis
  1. 6.1 Global Fertility Enhancing Treatment Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Fertility Enhancing Treatment Sales Value by Region (2021-2032)
  3. 6.2.1 Global Fertility Enhancing Treatment Sales Value by Region: 2021-2026
  4. 6.2.2 Global Fertility Enhancing Treatment Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Fertility Enhancing Treatment Sales Value (2021-2032)
  7. 6.3.2 North America Fertility Enhancing Treatment Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Fertility Enhancing Treatment Sales Value (2021-2032)
  10. 6.4.2 Europe Fertility Enhancing Treatment Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Fertility Enhancing Treatment Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Fertility Enhancing Treatment Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Fertility Enhancing Treatment Sales Value (2021-2032)
  16. 6.6.2 South America Fertility Enhancing Treatment Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Fertility Enhancing Treatment Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Fertility Enhancing Treatment Sales Value Share by Country, 2025 VS 2032
7 Fertility Enhancing Treatment Country-level Value Analysis
  1. 7.1 Global Fertility Enhancing Treatment Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Fertility Enhancing Treatment Sales Value by Country (2021-2032)
  3. 7.2.1 Global Fertility Enhancing Treatment Sales Value by Country (2021-2026)
  4. 7.2.2 Global Fertility Enhancing Treatment Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Fertility Enhancing Treatment Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Fertility Enhancing Treatment Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Fertility Enhancing Treatment Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Merck
  2. 8.1.1 Merck Company Information
  3. 8.1.2 Merck Business Overview
  4. 8.1.3 Merck Fertility Enhancing Treatment Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Merck Fertility Enhancing Treatment Product Portfolio
  6. 8.1.5 Merck Recent Developments
  7. 8.2 Ferring
  8. 8.2.1 Ferring Company Information
  9. 8.2.2 Ferring Business Overview
  10. 8.2.3 Ferring Fertility Enhancing Treatment Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ferring Fertility Enhancing Treatment Product Portfolio
  12. 8.2.5 Ferring Recent Developments
  13. 8.3 MSD
  14. 8.3.1 MSD Company Information
  15. 8.3.2 MSD Business Overview
  16. 8.3.3 MSD Fertility Enhancing Treatment Revenue and Gross Margin (2021-2026)
  17. 8.3.4 MSD Fertility Enhancing Treatment Product Portfolio
  18. 8.3.5 MSD Recent Developments
  19. 8.4 LIVZON
  20. 8.4.1 LIVZON Company Information
  21. 8.4.2 LIVZON Business Overview
  22. 8.4.3 LIVZON Fertility Enhancing Treatment Revenue and Gross Margin (2021-2026)
  23. 8.4.4 LIVZON Fertility Enhancing Treatment Product Portfolio
  24. 8.4.5 LIVZON Recent Developments
  25. 8.5 Abbott
  26. 8.5.1 Abbott Company Information
  27. 8.5.2 Abbott Business Overview
  28. 8.5.3 Abbott Fertility Enhancing Treatment Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Abbott Fertility Enhancing Treatment Product Portfolio
  30. 8.5.5 Abbott Recent Developments
  31. 8.6 Bayer Zydus Pharma
  32. 8.6.1 Bayer Zydus Pharma Company Information
  33. 8.6.2 Bayer Zydus Pharma Business Overview
  34. 8.6.3 Bayer Zydus Pharma Fertility Enhancing Treatment Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bayer Zydus Pharma Fertility Enhancing Treatment Product Portfolio
  36. 8.6.5 Bayer Zydus Pharma Recent Developments
  37. 8.7 Church＆Dwight
  38. 8.7.1 Church＆Dwight Company Information
  39. 8.7.2 Church＆Dwight Business Overview
  40. 8.7.3 Church＆Dwight Fertility Enhancing Treatment Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Church＆Dwight Fertility Enhancing Treatment Product Portfolio
  42. 8.7.5 Church＆Dwight Recent Developments
  43. 8.8 SASMAR
  44. 8.8.1 SASMAR Company Information
  45. 8.8.2 SASMAR Business Overview
  46. 8.8.3 SASMAR Fertility Enhancing Treatment Revenue and Gross Margin (2021-2026)
  47. 8.8.4 SASMAR Fertility Enhancing Treatment Product Portfolio
  48. 8.8.5 SASMAR Recent Developments
  49. 8.9 BioFilm,Inc
  50. 8.9.1 BioFilm,Inc Company Information
  51. 8.9.2 BioFilm,Inc Business Overview
  52. 8.9.3 BioFilm,Inc Fertility Enhancing Treatment Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BioFilm,Inc Fertility Enhancing Treatment Product Portfolio
  54. 8.9.5 BioFilm,Inc Recent Developments
  55. 8.10 FAIRHAVEN HEALTH
  56. 8.10.1 FAIRHAVEN HEALTH Company Information
  57. 8.10.2 FAIRHAVEN HEALTH Business Overview
  58. 8.10.3 FAIRHAVEN HEALTH Fertility Enhancing Treatment Revenue and Gross Margin (2021-2026)
  59. 8.10.4 FAIRHAVEN HEALTH Fertility Enhancing Treatment Product Portfolio
  60. 8.10.5 FAIRHAVEN HEALTH Recent Developments
  61. 8.11 The YES YES Company
  62. 8.11.1 The YES YES Company Company Information
  63. 8.11.2 The YES YES Company Business Overview
  64. 8.11.3 The YES YES Company Fertility Enhancing Treatment Revenue and Gross Margin (2021-2026)
  65. 8.11.4 The YES YES Company Fertility Enhancing Treatment Product Portfolio
  66. 8.11.5 The YES YES Company Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst